Descovy 200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJSEL
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,505
Award facts
- Contract value 100% obligated
- $12,504.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $12,504.84 by the Defense Logistics Agency on May 21, 2025, for the supply of DESCOVY 200-25 mg tablets in quantities of 30 units. The award carries an ultimate completion date of May 22, 2025, and was made without a set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.9 billion contract vehicle valid through November 2026 that enables the agency to issue firm fixed-price orders for comprehensive pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure consistent contract awards from the Defense Logistics Agency. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare facilities. The SPE2DB indefinite delivery contract under which this award was issued demonstrates the agency's confidence in the vendor's ability to reliably deliver diverse pharmaceutical products ranging from contraceptive medications to oncology treatments and specialty pharmaceuticals, positioning DMS Pharmaceutical Group as a key distribution partner for military medical supply needs.
Quick answers
Who was awarded contract SPE2DB25FJSEL?
SPE2DB25FJSEL was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on May 21, 2025.
How much is contract SPE2DB25FJSEL worth?
The government has obligated $12,505 on SPE2DB25FJSEL.
Is contract SPE2DB25FJSEL an order under another contract?
Yes. SPE2DB25FJSEL is a delivery order under SPE2DB24D9803, an indefinite delivery contract.
Was contract SPE2DB25FJSEL competed?
The extent of competition for SPE2DB25FJSEL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award